Price data is not available
HLS THERAPEUTICS INC by HLS Therapeutics Inc.
HLTRFOTCPK
HLS THERAPEUTICS INC by HLS Therapeutics fell 22.9% from $3.54 to $2.73, behind the S&P 500's +12.7%. Its worst day was Nov 12 (−14.7%), and its low came Sep 1 at $2.64.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
HLS THERAPEUTICS INC by HLS Therapeutics shares fell 10.8%, while the S&P 500 fell 0.3%.
−10.8% · S&P 500 −0.3%
HLS THERAPEUTICS INC by HLS Therapeutics closed at its lowest level of the year, 25.4% below where the year started.
Story events cover the past 12 months · Times ET
−2.2% · S&P 500 −0.7%
HLS THERAPEUTICS INC by HLS Therapeutics shares rose 16.2%, while the S&P 500 rose 0.7%.
+16.2%, the year's best day · S&P 500 +0.7%
Where it ended: a close of $2.73 on Nov 12, 2026.
Nothing in the past 12 months.
All HLTRF earningsNothing in the past 12 months.
All HLTRF analyst actionsNothing in the past 12 months.
All HLTRF dividend historyNothing in the past 12 months.
All HLTRF news
